Q-omics provides the consensus-scored MTCYBP39 profile across patient tissues and cancer cell-line models. MTCYBP39 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, MTCYBP39 RNA expression shows 4,278 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight LIHC, and COAD as cancer lineages where MTCYBP39 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MTCYBP39 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MTCYBP39 survival associations across molecular data types. MTCYBP39 RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MTCYBP39 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	7	LIHC (36)	view →

This table ranks reproducible MTCYBP39 RNA expression–survival associations across cancer types. High MTCYBP39 expression shows unfavorable associations in LIHC, PAAD, BLCA, LGG, KIRC and HNSC. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for MTCYBP39 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.015	0.784	<.001	36	view →
PAAD	DFS	Tertile	All	0.100	0.484	.003	36	view →
BLCA	OS	Tertile	IV	0.141	0.589	.018	27	view →
LGG	DFS	Tertile	All	0.238	0.731	.004	18	view →
KIRC	DFS	Tertile	II,III,IV	0.100	0.761	<.001	18	view →
HNSC	DFS	Tertile	II,III,IV	0.564	0.696	.046	12	view →

Pink = unfavorable, green = favorable. all 7 lineages →

MTCYBP39-LIHC (OS)

Kaplan–Meier survival curve for MTCYBP39 RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MTCYBP39 in patient tissues and cancer cell lines. In patient samples, MTCYBP39 shows the broadest associations at the RNA and protein expression levels, with COAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	4,278	COAD (2095)	view →
Function (RNA)	3,990	STAD (3612)	view →